HPSE and neoplasm: PG545 (a synthetic heparan sulphate mimetic that decreases heparanase expression) created by Progen Pharmaceuticals has been shown to suppress tumor growth in MDA-MB-231 xenografts and inhibit angiogenesis in animal studies [155].